Inventor · disambiguated record
Genesis M. Bacani
Also filed as: BACANI GENESIS · BACANI GENESIS M
18 granted patents·3 pending applications·46 citations·filing 2009–2024
92Inventor score
Top patents by PatentIndex Score
21 records- 0193US11827638B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·2 cites·3 claims
- 0291US12065446B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Aug 20, 2024·1 cites·4 claims
- 0391US10981911B2Imidazopyrrolopyridine as inhibitors of the JAK family of kinasesJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 20, 2021·6 cites·2 claims
- 0491US10717745B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jul 21, 2020·5 cites·26 claims
- 0590US10934310B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Mar 2, 2021·4 cites·7 claims
- 0686US9079866B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 14, 2015·8 cites·7 claims
- 0786US2024383914A1Inhibitors of bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0884US11319329B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·7 claims
- 0981US8367719B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 5, 2013·5 cites·21 claims
- 1079US8357684B2Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 22, 2013·5 cites·21 claims
- 1179US8344008B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 1, 2013·5 cites·4 claims
- 1275US7939527B2Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 10, 2011·2 cites·37 claims
- 1371US9884878B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 6, 2018·1 cites·6 claims
- 1471US9745328B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 29, 2017·1 cites·16 claims
- 1565US10800792B2Inhibitors of Bruton's tyrosine kinase and method of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Oct 13, 2020·0 cites·4 claims
- 1664US10822348B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2019·Granted Nov 3, 2020·0 cites·10 claims
- 1758US10689396B2Inhibitors of Bruton's tyrosine kinase and methods of their useJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Jun 23, 2020·0 cites·23 claims
- 1855US2024158392A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 1954US2024174662A1Small molecule inhibitors of salt inducible kinasesJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 2050US10172856B22,4-diaminopyrimidine derivatives as histamine H4 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 8, 2019·0 cites·22 claims
- 2128US8399465B2Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolaseBACANI GENESIS·Filed 2010·Granted Mar 19, 2013·0 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when Genesis M. Bacani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →